Avid Bioservices Inc (CDMO)

[Protector]

biopharm, this opens another possibility.

We have seen Zavoico move away in the past. Maybe Duncan leaves Piper Jaffray's. As posted by others PPHM was on PJ's main lists but no longer in Charles Duncan's.

The report must be comparable in scope and detail to prior research reports and must include a final recommendation or rating, unless it is impracticable for the member to produce a comparable report (e.g., if the research analyst covering the subject company or sector has left the member or if the member terminates coverage of the industry or sector).

Then again Charles Duncan's list should be empty altogether.